Hence, the transcriptomic data indicate the possibility that high DDX3X expression in liver cancer patients might trigger cancer progression, especially via metastasis, consistent with the observation of poor clinical outcomes (Figure 1B). This evidence concerns the gene DDX3X and cancer.